Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator

Daniel Merk1, Dieter Steinhilber, Manfred Schubert-Zsilavecz

  • 1Goethe-University Frankfurt, Institute of Pharmaceutical Chemistry , Max-von-Laue-Str. 9, D-60438 Frankfurt am Main , Germany merk@pharmchem.uni-frankfurt.de.

Abstract

Insights

Developing new Farnesoid X receptor (FXR) drugs requires robust in vitro tests. Current assays for FXR ligands are limited and may not fully assess drug candidates.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Farnesoid X receptor (FXR) is a key nuclear receptor involved in metabolic and inflammatory diseases.
  • FXR regulates gene transcription, making it a significant therapeutic target.

Purpose of the Study:

  • To review and evaluate existing in vitro test systems for characterizing Farnesoid X receptor (FXR) ligands.
  • To assess the adequacy of current assays for evaluating novel FXR-targeting drug candidates.

Main Methods:

  • Compilation and description of published cell-based functional assays and binding assays for FXR ligands.
  • Evaluation of the information obtainable from these diverse in vitro assays.

Main Results:

  • In vitro screening of FXR ligands predominantly utilizes reporter gene assays.
  • Co-activator recruitment assays and quantitative PCR (qPCR) for target gene analysis are also employed.
  • The range of available test systems for FXR is notably limited compared to other nuclear receptors like PPARs.

Conclusions:

  • Current in vitro assays may be insufficient for comprehensive characterization of FXR-targeting drug candidates.
  • Further development of diverse and robust test systems is needed for FXR ligand evaluation.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.7K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
8.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
9.1K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.2K